|
Creusot, Rémi J; Giannoukakis, Nick; Trucco, Massimo et al. (2014) It's time to bring dendritic cell therapy to type 1 diabetes. Diabetes 63:20-30
|
|
Yip, Linda; Fathman, C Garrison (2014) Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis. Immunol Res 58:340-50
|
|
Kurnellas, Michael P; Schartner, Jill M; Fathman, C Garrison et al. (2014) Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease. J Exp Med 211:1847-56
|
|
Yip, Linda; Taylor, Cariel; Whiting, Chan C et al. (2013) Diminished adenosine A1 receptor expression in pancreatic ?-cells may contribute to the pathology of type 1 diabetes. Diabetes 62:4208-19
|
|
Yip, Linda; Creusot, Remi J; Pager, Cara T et al. (2013) Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3. J Mol Cell Biol 5:99-110
|
|
Kurnellas, Michael P; Adams, Chris M; Sobel, Raymond A et al. (2013) Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation. Sci Transl Med 5:179ra42
|
|
Levin, Aron M; Bates, Darren L; Ring, Aaron M et al. (2012) Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature 484:529-33
|
|
Junttila, Ilkka S; Creusot, Remi J; Moraga, Ignacio et al. (2012) Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nat Chem Biol 8:990-8
|
|
Kurnellas, Michael P; Brownell, Sara E; Su, Leon et al. (2012) Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis. J Biol Chem 287:36423-34
|
|
Rothbard, Jonathan B; Kurnellas, Michael P; Brownell, Sara et al. (2012) Therapeutic effects of systemic administration of chaperone ?B-crystallin associated with binding proinflammatory plasma proteins. J Biol Chem 287:9708-21
|
Showing the most recent 10 out of 15 publications
